Eiji Kondo

35PUBLICATIONS
117CO-AUTHORS
Cancer cell biologyModels of care and place of birthCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMicrofluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 13, 2026
Microbiota-Derived Corisin Is Elevated in Early Cervical Neoplasia and Drives Pathogenic Cellular Programs.

|Jun 22, 2026
Maternal Complications and Facility-Level Differences in the Management of Placental Abruption in Japan: A Retrospective Analysis Using a Multicenter DPC Database.

|Mar 20, 2026
Feasibility and Outcomes of a Robotic Retroperitoneal Approach to Para-Aortic Lymphadenectomy in Intermediate- and High-Risk Endometrial Cancer: A Prospective Study.

Michiko Kubo-Kaneda, Kenta Yoshida, Saki Kotaka

|Feb 16, 2026
Efficacy of Postoperative Para-Aortic and Pelvic Lymphadenectomies for Intermediate- to High-Risk Endometrial Cancer.

Asumi Okumura, Kenta Yoshida, Saki Kotaka

|Jan 12, 2026
Comparative Evaluation of Two Microfluidic Sperm Sorting Devices: Laboratory Assessment of Sperm Quality and Retrospective Analysis of Embryological Outcomes Following Intracytoplasmic Sperm Injection.

Ryota Tachibana, Hiroki Takeuchi, Miyu Yotsutani

|Jul 01, 2025
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial.

Shin Nishio, Tadaaki Nishikawa, Masahiko Mori

Pageof 6

Frequent Collaborators

7 joint publications

Tomoaki Ikeda

7 joint publications

Tsutomu Tabata

6 joint publications

Michiko Kubo-Kaneda

6 joint publications

Masafumi Nii